Apogee Therapeutics Price Chart
Apogee Therapeutics Volume Chart
Apogee Therapeutics Market Segments
Premarket
*No Trades in Segment
After Hours Yesterday
+0.13(+0.17%)
| Open | $78.72 |
|---|---|
| Close | $78.85 |
| Low | $78.72 |
| Low Change | 0.00 (0.00%) |
| High | $78.85 |
| High Change | +0.13 (+0.17%) |
| Range | $0.13 |
| Volume | 5.094K |
| Dollar Volume | $401.66K |
Regular Trading Hours Yesterday
+0.67(+0.86%)
| Open | $78.04 |
|---|---|
| Close | $78.71 |
| Low | $76.60 |
| Low Change | -1.44 (-1.85%) |
| High | $79.95 |
| High Change | +1.91 (+2.44%) |
| Range | $3.35 |
| Volume | 834.298K |
| Dollar Volume | $65.67M |
Premarket Yesterday
+0.00(+0.00%)
| Open | $78.50 |
|---|---|
| Close | $78.50 |
| Low | $78.50 |
| Low Change | 0.00 (0.00%) |
| High | $78.50 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 100 |
| Dollar Volume | $7.85K |
Apogee Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $77.30 |
|---|---|
| 10 Day Moving Average (SMA10) | $73.71 |
| 20 Day Moving Average (SMA20) | $73.18 |
| 50 Day Moving Average (SMA50) | $71.21 |
| 100 Day Moving Average (SMA100) | $71.47 |
| 200 Day Moving Average (SMA200) | $56.69 |
Apogee Therapeutics Statistics
| Average Volume (30 Days) | 1.12M |
|---|---|
| P/E Ratio (Current) | -22.69 |
| EPS (Current) | -$3.43 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$232.60M |
| Cash Ratio | 4.71 |
| Current Ratio | 26.57 |
| Quick Ratio | 26.57 |
| Debt to Equity | 0.00 |
| Enterprise Value | $5.67B |
| EV to EBITDA | -19.97 |
| EV to Sales | — |
| Price to Book | 6.42 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.27% |
| Return on Equity | -0.28% |
Apogee Therapeutics Stock Splits
There has been 1 stock split for Apogee Therapeutics (APGE). The reverse stock split occured on January 8, 2008 and reduced the outstanding shares at a ratio of 50:1.
| Date | Type | Ratio |
|---|---|---|
| Jan 8, 2008 | Reverse | 50:1 |
Apogee Therapeutics Dividends
There have been no dividends for Apogee Therapeutics (APGE).